Skip to Content

Ebos Group Ltd

EBO: XNZE (NZL)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
NZD 33.60NjmsjShqffmbcgm

Ebos Earnings: Resilient Margins but Shares Are Expensive

Narrow-moat Ebos increased first-half fiscal 2024 revenue and underlying EBITDA by 7% and 8%, respectively, driven by creditable cost control and higher-margin medical technology. Group EBITDA margin expanded slightly by 5 basis points to 4.8% despite cost pressures in labor and freight.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of EBO so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center